Geographically-related outcomes of U.S. funding for small business research and development: Results of the research grant programs of a component of the National Institutes of Health.

Geography and innovation Research governance Research policy Small Business Innovation Research U.S. federal government University-industry links

Journal

Evaluation and program planning
ISSN: 1873-7870
Titre abrégé: Eval Program Plann
Pays: England
ID NLM: 7801727

Informations de publication

Date de publication:
12 2019
Historique:
received: 23 01 2019
revised: 30 04 2019
accepted: 30 07 2019
pubmed: 14 8 2019
medline: 10 10 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

This article examines the geographic distribution of funding for the U.S. Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs sponsored by the National Institute of General Medical Sciences (NIGMS). Despite a significant investment in SBIR/STTR and an interest in increasing geographic diversity in the institute's research portfolio, there has not been an assessment of the distribution of NIGMS's SBIR/STTR funding, outcomes associated with that investment, and relationships between the two. The geographic distribution of NIGMS' SBIR/STTR funding was highly concentrated in a small number of states, with a high correlation between each state's funding and its number of small scientific research and development businesses. Affiliation with a major research university was correlated with several measures of innovation and firm success. Our findings are consistent with earlier research showing that economic activity in research and development and research output tend to cluster in geographic regions where knowledge can be generated and shared more efficiently. These findings lend support to an investment strategy for small business research and development that creates networks between major research universities and small businesses.

Identifiants

pubmed: 31404866
pii: S0149-7189(19)30034-5
doi: 10.1016/j.evalprogplan.2019.101696
pmc: PMC6815264
mid: NIHMS1537203
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101696

Subventions

Organisme : Intramural NIH HHS
ID : Z99 GM999999
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Auteurs

James Onken (J)

Research Enterprise Analytics, LLC, Rockville, MD, 20850, United States.

Richard Aragon (R)

National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, 20892, United States.

Anna Maria Calcagno (AM)

National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, 20892, United States. Electronic address: anna.calcagno@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH